July 23, 2025

HER2DX Assay and Survival Outcomes in HER2-Positive Breast Cancer

In an individual patient-level meta-analysis reported in The Lancet Oncology, Villacampa et al found that the HER2DX assay risk score was prognostic for event-free survival outcomes in patients with e...

The ASCO Post

July 22, 2025

Short-Term Hormonal Treatment Offers Early Insight Into Tumor Behavior and Resistance for ER+/HER2+ Breast Cancer

How ER-positive, HER2-positive breast cancer tumors respond to a short course of hormonal treatment may help to determine whether more aggressive treatment options are necessary for each patient or no...

The ASCO Post

July 18, 2025

Can Use of Aprepitant During Chemotherapy Improve Triple-Negative Breast Cancer Outcomes?

A commonly used antiemetic may help to improve patient outcomes when given during chemotherapy treatment for women with early triple-negative breast cancer, study findings suggest.

The ASCO Post

July 15, 2025

Pivotal Presentations That May Shape the Breast Cancer Standard of Care

Anticipated updates in key breast cancer clinical trials at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting underscore “the importance of continued innovation in breast cancer therapy,” according to Reshma L. Mahtani, DO.

Baptist Health South Florida

July 10, 2025

A Powerful Team Researches Re-irradiation Options for Breast Cancer Recurrence

When breast cancer returns in a previously treated breast, the standard approach has been salvage mastectomy. The recently launched BRASIL trial (NCT06867484) aims to challenge this paradigm by investigating whether carefully selected patients can safely undergo repeat breast conservation with partial re-irradiation.

Baptist Health South Florida

January 25, 2023

SERENA-2 Trial: Camizestrant Improves Progression-Free Survival in Advanced Breast Cancer

The oral selective estrogen receptor degrader (SERD) camizestrant improved progression-free survival, as compared with fulvestrant, in previously treated postmenopausal women with advanced breast canc...

The ASCO Post

February 17, 2023

Association of Anthracycline Use With Risk of Congestive Heart Failure Among Patients Treated for Breast Cancer or Lymphoma

In a retrospective, population-based, case-control study reported in JAMA Network Open, Larsen et al found that patients receiving anthracyclines for breast cancer or lymphoma were at a significantly ...

The ASCO Post

February 06, 2023

WHO Launches New Roadmap on Breast Cancer

The World Health Organization (WHO) has released a new Global Breast Cancer Initiative Framework, providing a roadmap to attain targets to save 2.5 million lives from breast cancer by 2040. The new fr...

The ASCO Post

June 16, 2023

Study Evaluates Clinical Utility of Novel Liquid Biopsy-Breast Cancer Methylation Prototype Assay

A novel, automated liquid biopsy test—the Liquid Biopsy for Breast Cancer Methylation assay—may be effective at predicting early disease progression and potential survival outcomes in patients with me...

The ASCO Post